Depression in Childbearing Women: When Depression Complicates Pregnancy

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 151-165

  Marcus, Sheila M ^a   Heringhausen, Julie E ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Depression; Infant outcomes; Medication; Pregnancy; Psychotherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DIPHENHYDRAMINE; DOXEPIN; ESTRADIOL; FLUOXETINE; FLUVOXAMINE; LORAZEPAM; MIRTAZAPINE; NEFAZODONE; NORFLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; ALCOHOL CONSUMPTION; AMBIVALENCE; APPETITE DISORDER; CARDIOVASCULAR MALFORMATION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COLIC; DEPRESSION; DROWSINESS; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; GUILT; HEALTH CARE PERSONNEL; HOPELESSNESS; HUMAN; INTESTINE OBSTRUCTION; IRRITABILITY; JAUNDICE; LANGUAGE ABILITY; MAJOR DEPRESSION; MENTAL CONCENTRATION; MOTHER CHILD RELATION; MUSCLE HYPOTONIA; NERVOUSNESS; PREGNANCY; PREGNANT WOMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROLONGED CRYING; PSYCHOTHERAPY; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; REVIEW; SEIZURE; SEXUAL ABUSE; SIDE EFFECT; SLEEP DISORDER; SMOKING; SOCIAL SUPPORT; SPONTANEOUS ABORTION; STRESS; SUICIDAL IDEATION; SYMPTOM; SYNDACTYLY; TERATOGENICITY; URINE RETENTION; VOMITING; WEIGHT CHANGE;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MATERNAL WELFARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PSYCHOTHERAPY; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 60249096819     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.011     Document Type: Review

References (100)

1. Kessler R.C., Zhao S., Blazer D.G., et al. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 45 1-2 (1997) 19-30
2. Weissman M.M., and Olfson M. Depression in women: implications for health care research. Science 269 5225 (1995) 799-801
3. Gotlib I.H., Whiffen V.E., Mount J.H., et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 57 2 (1989) 269-274
4. Brown M.A., and Solchany J.E. Two overlooked mood disorders in women: subsyndromal depression and prenatal depression. Nurs Clin North Am 39 1 (2004) 83-95
5. Marcus S.M., Flynn H.A., Blow F.C., et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt) 12 4 (2003) 373-380
6. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111 4 (2008) 1001-1020
7. DSM-IV, Association AP. Diagnostic and statistical manual of mental disorders. No. 4th (1994), American Psychiatric Association, Washington, DC
8. Kumar R., and Robson K.M. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144 (1984) 35-47
9. Altshuler L.L., Cohen L.S., Moline M.L., et al. Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 7 3 (2001) 185-208
10. Westdahl C., Milan S., Magriples U., et al. Social support and social conflict as predictors of prenatal depression. Obstet Gynecol 110 1 (2007) 134-140
11. Ross A.S., Hall R.W., Frost K., et al. Antenatal & neonatal guidelines, education & learning system. J Ark Med Soc 102 12 (2006) 328-330
12. Altshuler L.L., Hendrick V., Cohen L.S., et al. Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 59 Suppl 2 (1998) 29-33
13. USPSTF. Screening for depression: recommendations and rationale. Ann Intern Med 136 10 (2002) 760-764
14. Feinman J.A., Cardillo D., Palmer J., et al. Development of a model for the detection and treatment of depression in primary care. Psychiatr Q 71 1 (2000) 59-78
15. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
16. Cox J.L., Holden J.M., Sagovsky R., et al. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 (1987) 782-786
17. Jardri R., Pelta J., Maron M., et al. Predictive validation study of the Edinburgh postnatal depression scale in the first week after delivery and risk analysis for postnatal depression. J Affect Disord 93 1-3 (2006) 169-176
18. Matthey S., Henshaw C., Elliott S., et al. Variability in use of cut-off scores and formats on the Edinburgh postnatal depression scale: implications for clinical and research practice. Arch Womens Ment Health 9 6 (2006) 309-315
19. Sharp L.K., and Lipsky M.S. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 66 6 (2002) 1001-1008
20. Katon W.J., and Seelig M. Population-based care of depression: team care approaches to improving outcomes. J Occup Environ Med 50 4 (2008) 459-467 (B)
21. Gilbody S., Bower P., Fletcher J., et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 166 21 (2006) 2314-2321
22. Zuckerman B., Amaro H., Bauchner H., et al. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol 160 5 Pt 1 (1989) 1107-1111
23. Chung T.K., Lau T.K., Yip A.S., et al. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63 5 (2001) 830-834
24. Wadhwa P.D., Sandman C.A., Porto M., et al. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 169 4 (1993) 858-865
25. Zuckerman B., Bauchner H., Parker S., et al. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11 4 (1990) 190-194
26. Wadhwa P.D., Dunkel-Schetter C., Chicz-DeMet A., et al. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med 58 5 (1996) 432-446
27. Teixeira J.M., Fisk N.M., Glover V., et al. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 318 7177 (1999) 153-157
28. Hoffman S., and Hatch M.C. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 19 6 (2000) 535-543
29. Heringhausen J, Marcus SM, Muzik M, et al. Neonatal sleep patterns and relationship to maternal depression (submitted). American Association of Child and Adolescent Psychiatry's 55th Annual Meeting. Chicago, IL; 2008.
30. Forman D.R., O'Hara M.W., Stuart S., et al. Effective treatment for postpartum depression is not sufficient to improve the developing mother-child relationship. Dev Psychopathol 19 2 (2007) 585-602
31. Coghill S., Caplan H., Alexandra H., et al. Impact of maternal postnatal depression on cognitive development of young children. Br Med J 292 (1986) 1165-1167
32. Alpern L., and Lyons-Ruth K. Preschool children at social risk: chronicity and timing of maternal depressive symptoms and child behavior problems at school and at home. Dev Psychopathol 5 (1993) 371-387
33. Field T. Infants of depressed mothers. Infant Behav Dev 18 (1995) 1-13
34. Lyons-Ruth K., Wolfe R., Lyubchik A., et al. Depression and the parenting of young children: making the case for early preventive mental health services. Harv Rev Psychiatry 8 3 (2000) 148-153
35. Weissman M.M., Prusoff B.A., Gammon G.D., et al. Psychopathology in the children (ages 6-18) of depressed and normal parents. J Am Acad Child Psychiatry 23 1 (1984) 78-84
36. Einarson A., Miropolsky V., Varma B., et al. Determinants of physicians' decision-making regarding the prescribing of antidepressant medication during pregnancy. Paper presented at the Fifteenth International Conference of the Organization of Teratology Information Services (OTIS). Scottsdale (AZ) (2002) p. 355-75
37. Gonsalves L., and Schuermeyer I. Treating depression in pregnancy: practical suggestions. Cleve Clin J Med 73 12 (2006) 1098-1104
38. Hostetter A., Stowe Z.N., Strader Jr. J.R., et al. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depress Anxiety 11 2 (2000) 51-57
39. Cohen L.S., Altshuler L.L., Harlow B.L., et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 5 (2006) 499-507
40. Hostetter A., Ritchie J.C., Stowe Z.N., et al. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 48 10 (2000) 1032-1034
41. Hemels M.E., Einarson A., Koren G., et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39 5 (2005) 803-809
42. Chun-Fai-Chan B., Koren G., Fayez I., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192 3 (2005) 932-936
43. Kulin N.A., Pastuszak A., Sage S.R., et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279 8 (1998) 609-610
44. Chambers C.D., Johnson K.A., Dick L.M., et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 14 (1996) 1010-1015
45. GlaxoSmithKline. Available at:. http://www.gsk.com/media/paroxetine/pregnancy_hcp_letter.pdf Accessed June 19, 2008
46. Einarson A., Pistelli A., DeSantis M., et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 165 6 (2008) 749-752
47. Alwan S., Reefhuis J., Rasmussen S.A., et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356 26 (2007) 2684-2692
48. Louik C., Lin A.E., Werler M.M., et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356 26 (2007) 2675-2683
49. Koren G., Matsui D., Einarson A., et al. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?. CMAJ 172 11 (2005) 1457-1459
50. Ferreira E., Carceller A.M., Agogue C., et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 119 1 (2007) 52-59
51. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 6 (2006) 579-587
52. Einarson A., Selby P., Koren G., et al. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 26 1 (2001) 44-48
53. Altshuler L.L., Cohen L., Szuba M.P., et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153 5 (1996) 592-606
54. Sharma V. A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord 8 4 (2006) 411-414
55. Schimmell M.S., Katz E.Z., Shaag Y., et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 29 4 (1991) 479-484
56. Nulman I., Rovet J., Stewart D.E., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 4 (1997) 258-262
57. Einarson T.R., and Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14 12 (2005) 823-827
58. Way C.M. Safety of newer antidepressants in pregnancy. Pharmacotherapy 27 4 (2007) 546-552
59. O'Hara M.W., Stuart S., Gorman L.L., et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 57 11 (2000) 1039-1045
60. Bhatia S.C., and Bhatia S.K. Depression in women: diagnostic and treatment considerations. Am Fam Physician 60 1 (1999) 225-234 239-40
61. Daley A.J., Macarthur C., Winter H., et al. The role of exercise in treating postpartum depression: a review of the literature. J Midwifery Womens Health 52 1 (2007) 56-62
62. Miller L.J. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45 5 (1994) 444-450 (B)
63. Steiner M. Perinatal mood disorders: position paper. Psychopharmacol Bull 34 3 (1998) 301-306
64. Hobfoll S.E., Ritter C., Lavin J., et al. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 63 3 (1995) 445-453
65. Logsdon M.C., and Usui W. Psychosocial predictors of postpartum depression in diverse groups of women. West J Nurs Res 23 6 (2001) 563-574
66. Secco M.L., Profit S., Kennedy E., et al. Factors affecting postpartum depressive symptoms of adolescent mothers. J Obstet Gynecol Neonatal Nurs 36 1 (2007) 47-54
67. Shanok A.F., and Miller L. Depression and treatment with inner city pregnant and parenting teens. Arch Womens Ment Health 10 5 (2007) 199-210
68. Epperson C.N. Postpartum major depression: detection and treatment. Am Fam Physician 59 8 (1999) 2247-2254 2259-60
69. Wisner K.L., Parry B.L., Piontek C.M., et al. Clinical practice. Postpartum depression. N Engl J Med 347 3 (2002) 194-199 (18)
70. Kendell R.E., Chalmers J.C., Platz C., et al. Epidemiology of puerperal psychoses. Br J Psychiatry 150 (1987) 662-673
71. O'Hara M.W., and Swain A.M. Rates and risk of postpartum depression-a meta-analysis. Int Rev Psychiatry 8 (1996) 37-54
72. Hannah P., Adams D., Lee A., et al. Links between early post-partum mood and post-natal depression. Br J Psychiatry 160 (1992) 777-780
73. Harlow B.L., Vitonis A.F., Sparen P., et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry 64 1 (2007) 42-48
74. Milgrom J., Gemmill A.W., Bilszta J.L., et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord 108 1-2 (2008) 147-157
75. Cooper P.J., and Murray L. Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry 166 2 (1995) 191-195
76. Wisner K.L., Perel J.M., Peindl K.S., et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 62 2 (2001) 82-86
77. Bloch M., Schmidt P.J., Danaceau M., et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157 6 (2000) 924-930
78. Wisner K.L., and Stowe Z.N. Psychobiology of postpartum mood disorders. Semin Reprod Endocrinol 15 1 (1997) 77-89
79. Gjerdingen D.K., and Yawn B.P. Postpartum depression screening: importance, methods, barriers, and recommendations for practice. J Am Board Fam Med 20 3 (2007) 280-288
80. Cohen L.S., Viguera A.C., Bouffard S.M., et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62 8 (2001) 592-596
81. Wisner K.L., Peindl K.S., Gigliotti T.V., et al. Tricyclics vs. SSRIs for postpartum depression. Arch Womens Ment Health 1 (1999) 189-191
82. Wisner K.L., Perel J.M., Peindl K.S., et al. Effects of the postpartum period on nortriptyline pharmacokinetics. Psychopharmacol Bull 33 2 (1997) 243-248
83. Stowe Z.N., Owens M.J., Landry J.C., et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. American Journal of Psychiatry 154 9 (1997) 1255-1260
84. Spigset O., Carleborg L., Norstrom A., et al. Paroxetine level in breast milk. J Clin Psychiatry 57 1 (1996) 39
85. Kristensen J.H., Ilett K.F., Hackett L.P., et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 48 4 (1999) 521-527 (B)
86. Lester B.M., Cucca J., Andreozzi L., et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 32 6 (1993) 1253-1255 (B)
87. Yoshida K., Smith B., Craggs M., et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 43 3 (1997) 225-237
88. Hale T.W. Drug therapy and breastfeeding: antidepressants, antipsychotics, antimanics, and sedatives. Neo Revs 5 10 (2004) e451-e456
89. Kristensen J.H., Ilett K.F., Rampono J., et al. Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol 63 3 (2007) 322-327
90. Verbeeck R.K., Ross S.G., McKenna E.A., et al. Excretion of trazodone in breast milk. Br J Clin Pharmacol 22 3 (1986) 367-370
91. Yapp P., Ilett K.F., Kristensen J.H., et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 34 11 (2000) 1269-1272
92. Chaudron L.H., and Schoenecker C.J. Bupropion and breastfeeding: a case of a possible infant seizure. J Clin Psychiatry 65 6 (2004) 881-882
93. Ringdahl E.N., Pereira S.L., Delzell Jr. J.E., et al. Treatment of primary insomnia. J Am Board Fam Pract 17 3 (2004) 212-219
94. Summerfield R.J., and Nielsen M.S. Excretion of lorazepam into breast milk. Br J Anaesth 57 10 (1985) 1042-1043
95. Johnstone M.J. The effect of lorazepam on neonatal feeding behaviour at term. Pharmatherapeutica 3 4 (1982) 259-262
96. Milgrom J., Negri L.M., Gemmill A.W., et al. A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol 44 Pt 4 (2005) 529-542 (A)
97. Flynn HA, Henshaw E, O'Mahen H, et al. In: Team UoMDoPP Personalizing CBT for perinatal depression: results of a qualitative study on improving intervention engagement and effectiveness. Ann Arbor. 2008.
98. Gay C.L., Lee K.A., Lee S.Y., et al. Sleep patterns and fatigue in new mothers and fathers. Biol Res Nurs 5 4 (2004) 311-318
99. Gregoire A.J., Kumar R., Everitt B., et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347 9006 (1996) 930-933
100. Lawrie T.A., Hofmeyr G.J., De Jager M., et al. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 105 10 (1998) 1082-1090